# Allogene Therapeutics, Inc.: Form 8-K, filed Oct 7, 2024

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 16:28 ET
- Period: 2024-10-03
- Accession: 0001737287-24-000062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/allo-20241003.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/

## Items reported

- Item 5.05: Item not in the standard list
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/allo-20241003.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001737287-24-000062. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
